{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/dental-abscess/prescribing-information/phenoxymethylpenicillin/","result":{"pageContext":{"chapter":{"id":"91946ef3-8703-52eb-ba0a-b9cabca622e5","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin","depth":2,"htmlHeader":"<!-- begin field cfca62b8-7d4c-4adb-83ee-a6fe00fe4fc8 --><h2>Phenoxymethylpenicillin</h2><!-- end field cfca62b8-7d4c-4adb-83ee-a6fe00fe4fc8 -->","summary":"","htmlStringContent":"<!-- begin item 7f839f69-9f98-4ddb-a315-a6fe00fe4ec2 --><!-- end item 7f839f69-9f98-4ddb-a315-a6fe00fe4ec2 -->","topic":{"id":"d9ce8bcf-6a30-56c3-9028-f291f9b80333","topicId":"7e8f6d78-0b6f-4813-baa8-3184010dd768","topicName":"Dental abscess","slug":"dental-abscess","lastRevised":"Last revised in October 2018","chapters":[{"id":"82801101-5e68-547d-8c3c-4ad6ec3b91b9","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"92e4cbdc-7fa7-574b-bb17-97199587fe2d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"e4034c8e-5cd0-5dc4-ba1d-f3ca1fe09c21","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"84291395-fd80-58ef-a144-855cbf9b7b46","slug":"changes","fullItemName":"Changes"},{"id":"07b47e29-f600-5771-917c-4d6cd9135ed2","slug":"update","fullItemName":"Update"}]},{"id":"e967b353-dcf8-5e71-a9b0-95ca162918b8","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"244fc23b-f275-5565-b50c-dca750baa8d9","slug":"goals","fullItemName":"Goals"},{"id":"1eb55d27-8795-5d81-8b81-4b4b6b7efa18","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2423d7f3-a323-50a3-8bbd-9664897bccd4","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f5780547-92b5-5ede-a620-c7cf34a41b3b","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e9cfdeb1-ec38-5e0d-b03e-0acd118058b8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"fa0115e4-0051-5374-8fae-1e1fbec27b97","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"5f20011b-3e94-5351-a2a6-2a9565c42d7a","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"69b7a1cd-7d22-52ab-b602-3a0c4bfbb4d4","slug":"definition","fullItemName":"Definition"},{"id":"617d13f2-34cd-5fd2-8869-198c3a3d5f06","slug":"causes","fullItemName":"Causes"},{"id":"777f9b6b-175c-5308-bba6-916d89e075b3","slug":"prevalence","fullItemName":"Prevalence"},{"id":"cf5def0d-1ffd-5d57-b788-273fc8248d5c","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"735fc661-47ce-5a94-a29f-f0076c17ce88","slug":"complications","fullItemName":"Complications"}]},{"id":"df647f07-2727-5ac9-b87c-5adcdcf79bd6","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"b2a41850-a8dc-5b90-a7c5-4f2216c54cd2","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"d97daa33-59c0-5607-a1fe-03238b7b333f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"6b0a689b-1ec7-5794-a5f0-b4efc84acfd2","fullItemName":"Management","slug":"management","subChapters":[{"id":"e6487762-ae28-5710-865a-01603c95176a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"86cee72a-afc7-5150-92f0-6ff0e90b0172","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a9ed2df0-8168-51d7-b8e8-f5bb7c662d36","slug":"analgesics","fullItemName":"Analgesics"},{"id":"c8a5d71d-6f87-5315-aa1f-59791511dafe","slug":"amoxicillin","fullItemName":"Amoxicillin"},{"id":"9bd34406-b8a3-5ab1-8a5d-3bd78925ef32","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"03d761c0-a760-5547-8910-97a65535bf94","slug":"metronidazole","fullItemName":"Metronidazole"},{"id":"91946ef3-8703-52eb-ba0a-b9cabca622e5","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"9c1469e7-dbca-5eaa-b2cd-29e127addf9a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"aac7c7e4-eb79-5922-8ea7-3250adfae6b3","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5aabd034-b3df-5bf4-93c1-30787cb35e17","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"6420441b-a18d-5bdb-a114-17409f623a23","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"65e26e16-4508-5e81-a8bf-307836e310cd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0aba46be-7078-5b8a-8557-56574cc69291","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"2d089d7b-e753-518e-95f6-04243be55427","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f724f89d-9d85-5d8b-9675-d551cbf4aa5e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"86cee72a-afc7-5150-92f0-6ff0e90b0172","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"57f9cff0-a64d-539b-81d3-3255843e2604","slug":"dose","fullItemName":"Dose","depth":3,"htmlHeader":"<!-- begin field 4bcaa7c6-470c-4c60-8b0c-a71900f0190f --><h3>What dose of phenoxymethypenicillin should I prescribe?</h3><!-- end field 4bcaa7c6-470c-4c60-8b0c-a71900f0190f -->","summary":"","htmlStringContent":"<!-- begin item 3e3a8f46-eaa1-41b2-b1f0-a71900f01945 --><!-- begin field 3a4f1d7b-3d3e-40fd-a71a-a71900f0190f --><ul><li>For dental abscess, prescribe a 5 day course of phenoxymethylpenicillin (review after 3 days):<ul><li>Adults: 500 mg to 1 gram four times a day. </li><li>Child 12–18 years: 500 mg four times daily.</li><li>Child 6–12 years: 250 mg four times daily. </li><li>Child 1–6 years: 125 mg four times daily. </li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">BNF for Children, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">PHE, 2017</a>]</p><!-- end field 3a4f1d7b-3d3e-40fd-a71a-a71900f0190f --><!-- end item 3e3a8f46-eaa1-41b2-b1f0-a71900f01945 -->","subChapters":[]},{"id":"518e4165-ae49-58b6-a3f9-93578bddc627","slug":"cautions-contraindications","fullItemName":"Cautions and contraindications","depth":3,"htmlHeader":"<!-- begin field 78b13b3c-7066-43da-a9f9-a6fe00fef63d --><h3>What are the cautions and contraindications associated with phenoxymethylpenicillin?</h3><!-- end field 78b13b3c-7066-43da-a9f9-a6fe00fef63d -->","summary":"","htmlStringContent":"<!-- begin item 86bfd511-6d53-448c-a8d5-a6fe00fef4f9 --><!-- begin field bbbbb721-0f39-4b78-8bb3-a6fe00fef63d --><ul><li><strong>Do not prescribe phenoxymethylpenicillin (penicillin V)</strong> to people with a true penicillin hypersensitivity. Gastrointestinal adverse effects alone (such as nausea, vomiting, or diarrhoea) do not constitute an allergy to penicillin. </li><li><div>Prescribe penicillin V with caution in people with:</div><ul><li>Hypersensitivity to cephalosporins — there is some evidence of partial cross-allergenicity. </li><li>Renal impairment — reduce dose. </li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">ABPI Medicines Compendium, 2017b</a>]</p><!-- end field bbbbb721-0f39-4b78-8bb3-a6fe00fef63d --><!-- end item 86bfd511-6d53-448c-a8d5-a6fe00fef4f9 -->","subChapters":[]},{"id":"48fb38ed-f4cd-510f-8535-f8ca78f703bc","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 6195bc76-b16c-4f8c-8f0e-a6fe00ff0b6c --><h3>What are the adverse effects of phenoxymethylpenicillin?</h3><!-- end field 6195bc76-b16c-4f8c-8f0e-a6fe00ff0b6c -->","summary":"","htmlStringContent":"<!-- begin item 8c5b8aaa-6a4d-4cad-8507-a6fe00ff0a79 --><!-- begin field 0104447d-2c44-4eb8-ac00-a6fe00ff0b6c --><ul><li><strong>Adverse effects of </strong><strong>phenoxymethylpenicillin (penicillin V) include:</strong><ul><li>Hypersensitivity reactions including urticaria, fever, joint pains, rashes, angio-oedema, anaphylaxis, and serum sickness-like reaction.</li><li><!--      -->Interstitial nephritis. </li><li><!--      -->Haemolytic anaemia, leucopenia, thrombocytopenia, and coagulation disorders.</li><li><!--      -->Diarrhoea, nausea and vomiting.<ul><li><!--      -->Severe diarrhoea during or after treatment with antibiotics may be a sign of pseudomembranous colitis. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li></ul></li><li>Rarely central nervous system toxicity including convulsions (especially with high doses or in severe renal impairment).</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">ABPI Medicines Compendium, 2017b</a>]</p><!-- end field 0104447d-2c44-4eb8-ac00-a6fe00ff0b6c --><!-- end item 8c5b8aaa-6a4d-4cad-8507-a6fe00ff0a79 -->","subChapters":[]},{"id":"ace8d080-1083-5ebf-bcbd-2c3c9c5c11fb","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 8085327f-c5c3-4f59-b534-a6fe00ff2136 --><h3>What drug interactions are important with phenoxymethylpenicillin?</h3><!-- end field 8085327f-c5c3-4f59-b534-a6fe00ff2136 -->","summary":"","htmlStringContent":"<!-- begin item e1c0d11d-a949-44ce-8597-a6fe00ff1fee --><!-- begin field 891abd16-516d-4cf8-96a7-a6fe00ff2136 --><ul><li><strong>Possible drug interactions with phenoxymethylpenicillin (penicillin V) include:</strong><ul><li>Anticoagulants — an interaction between broad-spectrum penicillins and coumarins or phenidone has not been demonstrated in studies, but common experience is that the International Normalised Ratio (INR) can be altered.<ul><li>Increase monitoring of coagulation status — check INR within 3 days of starting phenoxymethylpenicillin [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">Preston, 2016</a>].</li></ul></li><li>Methotrexate — penicillins reduce excretion of methotrexate (increased risk of toxicity). <ul><li>Monitor levels of methotrexate more closely. One recommendation is to carry out twice weekly platelet and white cell counts for 2 weeks initially, with the measurement of methotrexate levels if toxicity is suspected [<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">Preston, 2016</a>].</li></ul></li></ul></li><li>Oral hormonal contraception — additional contraceptive precautions are not required during or after courses of penicillins. However, advise women on the importance of correct contraceptive practice if they experience vomiting or diarrhoea. For further information, see the section on vomiting or diarrhoea in the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/contraception-combined-hormonal-methods/\">Contraception - combined hormonal methods</a> and <a class=\"topic-reference external-reference\" href=\"/topics/contraception-progestogen-only-methods/\">Contraception - progestogen-only methods</a>.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">FSRH, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">BNF 72, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/dental-abscess/references/\">ABPI Medicines Compendium, 2017b</a>]</p><!-- end field 891abd16-516d-4cf8-96a7-a6fe00ff2136 --><!-- end item e1c0d11d-a949-44ce-8597-a6fe00ff1fee -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}